EarningsQ4 2024 Earnings Report

Cannara Biotech (LOVFF) Q4 2024 Earnings Report

12 Followers

LOVFF Q4 2024 EPS Results

Actual EPS$0.05

Consensus EPS―

Beat/Miss―

One Year Ago EPS$0.04

Actual Revenue$16.56M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+20.30%

QuarterQ4 2024

Date11/25/2024

TimeBefore Open

Conference CallMonday, November 25, 2024

LOVFF Upcoming Earnings

Cannara Biotech's next earnings date is estimated for November 24, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 24, 2026	2026 (Q4)	0.03 / -	0.028	―
Jul 15, 2026	2026 (Q3)	0.04 / 0.04	0.028	25.00% (<+0.01)
Apr 14, 2026	2026 (Q2)	0.04 / 0.01	0.026	-45.95% (-0.01)
Jan 26, 2026	2026 (Q1)	- / <0.01	0.018	-61.54% (-0.01)
Nov 24, 2025	2025 (Q4)	- / 0.03	0.045	-37.50% (-0.02)
Jul 28, 2025	2025 (Q3)	- / 0.03	0.016	81.82% (+0.01)
Apr 28, 2025	2025 (Q2)	- / 0.03	-0.027	197.37% (+0.05)
Jan 27, 2025	2025 (Q1)	- / 0.02	0.016	13.04% (<+0.01)
Nov 25, 2024	2024 (Q4)	- / 0.05	0.036	25.49% (<+0.01)
Jul 23, 2024	2024 (Q3)	- / 0.02	0.023	-33.33% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed